Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis

Journal of Periodontal Research

Volumn 46, Issue 5, 2011, Pages 592-598

  Özçaka, Ö ^a   Nalbantsoy, A ^a   Buduneli, N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Interleukin 17; Interleukin 18; Periodontitis; Plasma; Saliva

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 17; INTERLEUKIN 18; SALIVA PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTICS; SALIVA;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-18; MALE; MIDDLE AGED; PERIODONTAL INDEX; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 80051869898     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01377.x     Document Type: Article

References (53)

1. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41.
2. Seymour GJ, Gemmell E. Cytokines in periodontal disease: where to from here? Acta Odontol Scand 2001;59:167-173.
3. Yao Z, Painter SL, Fanslow WC et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-5486.
4. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485-517.
5. Lubberts E, van den Bersselaar L, Oppers-Walgreen B et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 2003;170:2655-2662.
6. Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007;78:1083-1093.
7. Yu JJ, Ruddy MJ, Wong GC et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007;109:3794-3802.
8. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005;32:369-374.
9. Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gammonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389.
10. Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007;86:347-351.
11. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311-321.
12. Dinarello CA. Interleukin-18. Methods 1999;19:121-132.
13. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-224.
14. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000;11:483-486.
15. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38.
16. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-550.
17. Puren AJ, Razeghi P, Fantuzzi G, Dinarello CA. Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. J Infect Dis 1998;178:1830-1834.
18. Figueredo CM, Rescala B, Teles RP et al. Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiol Immunol 2008;23:173-176.
19. Johnson RB, Serio FG. Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 2005;76:785-790.
20. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A. Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 2005;76:75-82.
21. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-18 and periodontal disease. J Dent Res 2007;86:586-593.
22. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 2006;21:256-260.
23. Pradeep AR, Happy D, Hadge P, Garg G, Thorat M. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. J Periodontol 2009;80:1454-1461.
24. Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006;137:322-329.
25. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
26. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72-77.
27. Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999;26:352-357.
28. Buduneli N, Biyikoǧlu B, Sherrabeh S, Lappin DF. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol 2008;35:846-852.
29. Özçaka Ö, Biçakci N, Pussinen P, Sorsa T, Köse T, Buduneli N. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis 2011;17:68-76.
30. Kaufman E, Lamster I. Analysis of saliva for periodontal diagnosis. J Clin Periodontol 2000;27:453-465.
31. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J 1992;172:305-312.
32. Chapple IL, Mason GI, Garner I et al. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997;34:412-421.
33. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008;223:87-113.
34. Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 2008;13:170-177.
35. Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007;78:1545-1550.
36. Yetkin Ay Z, Sütçü R, Uskun E, Bozkurt FY, Berker E. The impact of the IL-11:IL-17 ratio on the chronic periodontitis pathogenesis: a preliminary report. Oral Dis 2009;15:93-98.
37. Buduneli N, Buduneli E, Kütükçüler N. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol 2009;80:1274-1280.
38. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004;75:37-43.
39. Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008;87:817-828.
40. Ohyama H, Kato-Kogoe N, Kuhara A et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009;88:633-638.
41. Honda T, Aoki Y, Takahashi N et al. Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin Chim Acta 2008;395:137-141.
42. Cardoso CR, Garlet GP, Crippa GE et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009;24:1-6.
43. Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL)-17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol 2009;36:396-403.
44. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010;89:943-947.
45. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-474.
46. Tschoeke SK, Oberholzer A, Moldawer LL. Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 2006;34:1225-1233.
47. Schallhorn RA, Patel DN, Chandrasekar B, Mealey BL. Periodontal disease in association with systemic levels of interleukin-18 and CXC ligand 16 in patients undergoing cardiac catheterization. J Periodontol 2010;81:1180-1186.
48. Yamamura M, Kawashima M, Taniai M et al. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 2001;44:275-285.
49. Ushio S, Namba M, Okura T et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein. J Immunol 1996;156:4274-4279.
50. Beklen A, Sorsa T, Konttinen YT. Toll-like receptors 2 and 5 in human gingival epithelial cells co-operate with T-cell cytokine interleukin-17. Oral Microbiol Immunol 2009;24:38-42.
51. Buduneli N, Özçaka Ö, Nalbantsoy A. Salivary and plasma levels of Toll-like receptor 2 and Toll-like receptor 4 in chronic periodontitis. J Periodontol 2011;82. (in press) doi.
52. Sorsa T, Hernandez M, Leppilahti J, Munjal S, Netuschil L, Mantyla P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis 2010;16:39-45.
53. Leppilahti JM, Ahonen M-M, Hernandez M et al. Oral rinse MMP-8 point-of-care immune test identifies patients with strong periodontal inflammatory burden. Oral Dis 2011;17:115-122.